Karen Ling

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Debra E. Levin, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Karen Ling:

Form 4 holding Director

TherapeuticsMD, Inc.

Security class
Restricted Stock Units
Shares / value
5,000
Estimated value
$18,191
Report date
29 Sep 2022
Price
$3.64
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Mallinckrodt plc

Security class
Ordinary Shares
Shares / value
0
Estimated value
Report date
14 Nov 2023
Price
$37.50
Ownership
Direct

Insider Reports Filed by Karen Ling

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .